3-chloro-6-[[(2S)-2-[3-[2-chloro-5-(1-chloro-3-oxo-5,6,7,8-tetrahydropyrazolo[1,2-a]pyridazin-2-yl)phenoxy]cyclopentyl]cyclopropyl]methyl]-2-(4-chloro-3-hydroxyphenyl)-5,6,7,8-tetrahydropyrazolo[1,2-a]pyridazin-1-one

C35H36Cl4N4O4 — CID 144704559

IUPAC3-chloro-6-[[(2S)-2-[3-[2-chloro-5-(1-chloro-3-oxo-5,6,7,8-tetrahydropyrazolo[1,2-a]pyridazin-2-yl)phenoxy]cyclopentyl]cyclopropyl]methyl]-2-(4-chloro-3-hydroxyphenyl)-5,6,7,8-tetrahydropyrazolo[1,2-a]pyridazin-1-one
SMILESO=c1c(-c2ccc(Cl)c(OC3CCC([C@H]4CC4CC4CCn5c(=O)c(-c6ccc(Cl)c(O)c6)c(Cl)n5C4)C3)c2)c(Cl)n2n1CCCC2
InChIInChI=1S/C35H36Cl4N4O4/c36-26-7-4-21(16-28(26)44)30-33(39)43-18-19(9-12-42(43)35(30)46)13-23-15-25(23)20-3-6-24(14-20)47-29-17-22(5-8-27(29)37)31-32(38)40-10-1-2-11-41(40)34(31)45/h4-5,7-8,16-17,19-20,23-25,44H,1-3,6,9-15,18H2/t19?,20?,23?,24?,25-/m1/s1
InChIKeyUADHWTROXYDLFZ-BKAZTDBQSA-N
MW718.51 g/mol
LogP8.35
Rot. Bonds7

About 3-chloro-6-[[(2S)-2-[3-[2-chloro-5-(1-chloro-3-oxo-5,6,7,8-tetrahydropyrazolo[1,2-a]pyridazin-2-yl)phenoxy]cyclopentyl]cyclopropyl]methyl]-2-(4-chloro-3-hydroxyphenyl)-5,6,7,8-tetrahydropyrazolo[1,2-a]pyridazin-1-one

3-chloro-6-[[(2S)-2-[3-[2-chloro-5-(1-chloro-3-oxo-5,6,7,8-tetrahydropyrazolo[1,2-a]pyridazin-2-yl)phenoxy]cyclopentyl]cyclopropyl]methyl]-2-(4-chloro-3-hydroxyphenyl)-5,6,7,8-tetrahydropyrazolo[1,2-a]pyridazin-1-one (PubChem CID 144704559) has the molecular formula C35H36Cl4N4O4 and a molecular weight of 718.51 g/mol. Its IUPAC name is 3-chloro-6-[[(2S)-2-[3-[2-chloro-5-(1-chloro-3-oxo-5,6,7,8-tetrahydropyrazolo[1,2-a]pyridazin-2-yl)phenoxy]cyclopentyl]cyclopropyl]methyl]-2-(4-chloro-3-hydroxyphenyl)-5,6,7,8-tetrahydropyrazolo[1,2-a]pyridazin-1-one.

Molecular Properties

Compound Name3-chloro-6-[[(2S)-2-[3-[2-chloro-5-(1-chloro-3-oxo-5,6,7,8-tetrahydropyrazolo[1,2-a]pyridazin-2-yl)phenoxy]cyclopentyl]cyclopropyl]methyl]-2-(4-chloro-3-hydroxyphenyl)-5,6,7,8-tetrahydropyrazolo[1,2-a]pyridazin-1-one
PubChem CID144704559
Molecular FormulaC35H36Cl4N4O4
Molecular Weight718.51 g/mol
Exact Mass716.15
IUPAC Name3-chloro-6-[[(2S)-2-[3-[2-chloro-5-(1-chloro-3-oxo-5,6,7,8-tetrahydropyrazolo[1,2-a]pyridazin-2-yl)phenoxy]cyclopentyl]cyclopropyl]methyl]-2-(4-chloro-3-hydroxyphenyl)-5,6,7,8-tetrahydropyrazolo[1,2-a]pyridazin-1-one
SMILESO=c1c(-c2ccc(Cl)c(OC3CCC([C@H]4CC4CC4CCn5c(=O)c(-c6ccc(Cl)c(O)c6)c(Cl)n5C4)C3)c2)c(Cl)n2n1CCCC2
InChIInChI=1S/C35H36Cl4N4O4/c36-26-7-4-21(16-28(26)44)30-33(39)43-18-19(9-12-42(43)35(30)46)13-23-15-25(23)20-3-6-24(14-20)47-29-17-22(5-8-27(29)37)31-32(38)40-10-1-2-11-41(40)34(31)45/h4-5,7-8,16-17,19-20,23-25,44H,1-3,6,9-15,18H2/t19?,20?,23?,24?,25-/m1/s1
InChIKeyUADHWTROXYDLFZ-BKAZTDBQSA-N
XLogP8.35
TPSA83.32 Ų
H-Bond Donors1
H-Bond Acceptors8
Rotatable Bonds7
Heavy Atoms47
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500718.51
LogP ≤ 58.35
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 108

Analyze 3-chloro-6-[[(2S)-2-[3-[2-chloro-5-(1-chloro-3-oxo-5,6,7,8-tetrahydropyrazolo[1,2-a]pyridazin-2-yl)phenoxy]cyclopentyl]cyclopropyl]methyl]-2-(4-chloro-3-hydroxyphenyl)-5,6,7,8-tetrahydropyrazolo[1,2-a]pyridazin-1-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 3-chloro-6-[[(2S)-2-[3-[2-chloro-5-(1-chloro-3-oxo-5,6,7,8-tetrahydropyrazolo[1,2-a]pyridazin-2-yl)phenoxy]cyclopentyl]cyclopropyl]methyl]-2-(4-chloro-3-hydroxyphenyl)-5,6,7,8-tetrahydropyrazolo[1,2-a]pyridazin-1-one?
The IUPAC name of 3-chloro-6-[[(2S)-2-[3-[2-chloro-5-(1-chloro-3-oxo-5,6,7,8-tetrahydropyrazolo[1,2-a]pyridazin-2-yl)phenoxy]cyclopentyl]cyclopropyl]methyl]-2-(4-chloro-3-hydroxyphenyl)-5,6,7,8-tetrahydropyrazolo[1,2-a]pyridazin-1-one (CID 144704559) is 3-chloro-6-[[(2S)-2-[3-[2-chloro-5-(1-chloro-3-oxo-5,6,7,8-tetrahydropyrazolo[1,2-a]pyridazin-2-yl)phenoxy]cyclopentyl]cyclopropyl]methyl]-2-(4-chloro-3-hydroxyphenyl)-5,6,7,8-tetrahydropyrazolo[1,2-a]pyridazin-1-one.
What is the SMILES notation for 3-chloro-6-[[(2S)-2-[3-[2-chloro-5-(1-chloro-3-oxo-5,6,7,8-tetrahydropyrazolo[1,2-a]pyridazin-2-yl)phenoxy]cyclopentyl]cyclopropyl]methyl]-2-(4-chloro-3-hydroxyphenyl)-5,6,7,8-tetrahydropyrazolo[1,2-a]pyridazin-1-one?
The canonical SMILES for 3-chloro-6-[[(2S)-2-[3-[2-chloro-5-(1-chloro-3-oxo-5,6,7,8-tetrahydropyrazolo[1,2-a]pyridazin-2-yl)phenoxy]cyclopentyl]cyclopropyl]methyl]-2-(4-chloro-3-hydroxyphenyl)-5,6,7,8-tetrahydropyrazolo[1,2-a]pyridazin-1-one is O=c1c(-c2ccc(Cl)c(OC3CCC([C@H]4CC4CC4CCn5c(=O)c(-c6ccc(Cl)c(O)c6)c(Cl)n5C4)C3)c2)c(Cl)n2n1CCCC2.
What is the InChIKey of 3-chloro-6-[[(2S)-2-[3-[2-chloro-5-(1-chloro-3-oxo-5,6,7,8-tetrahydropyrazolo[1,2-a]pyridazin-2-yl)phenoxy]cyclopentyl]cyclopropyl]methyl]-2-(4-chloro-3-hydroxyphenyl)-5,6,7,8-tetrahydropyrazolo[1,2-a]pyridazin-1-one?
The InChIKey is UADHWTROXYDLFZ-BKAZTDBQSA-N. The full InChI is InChI=1S/C35H36Cl4N4O4/c36-26-7-4-21(16-28(26)44)30-33(39)43-18-19(9-12-42(43)35(30)46)13-23-15-25(23)20-3-6-24(14-20)47-29-17-22(5-8-27(29)37)31-32(38)40-10-1-2-11-41(40)34(31)45/h4-5,7-8,16-17,19-20,23-25,44H,1-3,6,9-15,18H2/t19?,20?,23?,24?,25-/m1/s1.
What are the key properties of 3-chloro-6-[[(2S)-2-[3-[2-chloro-5-(1-chloro-3-oxo-5,6,7,8-tetrahydropyrazolo[1,2-a]pyridazin-2-yl)phenoxy]cyclopentyl]cyclopropyl]methyl]-2-(4-chloro-3-hydroxyphenyl)-5,6,7,8-tetrahydropyrazolo[1,2-a]pyridazin-1-one?
3-chloro-6-[[(2S)-2-[3-[2-chloro-5-(1-chloro-3-oxo-5,6,7,8-tetrahydropyrazolo[1,2-a]pyridazin-2-yl)phenoxy]cyclopentyl]cyclopropyl]methyl]-2-(4-chloro-3-hydroxyphenyl)-5,6,7,8-tetrahydropyrazolo[1,2-a]pyridazin-1-one has a molecular weight of 718.51 g/mol, XLogP of 8.35, 7 rotatable bonds, 1 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for 3-chloro-6-[[(2S)-2-[3-[2-chloro-5-(1-chloro-3-oxo-5,6,7,8-tetrahydropyrazolo[1,2-a]pyridazin-2-yl)phenoxy]cyclopentyl]cyclopropyl]methyl]-2-(4-chloro-3-hydroxyphenyl)-5,6,7,8-tetrahydropyrazolo[1,2-a]pyridazin-1-one is sourced from PubChem (CID 144704559), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).